Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Bidirectional GPR119 agonism requires peptide YY and glucose for activity in mouse and human colon mucosa
Competing interests JC: provided consultation to Acadia, Actinogen, Acumen, Alpha Cognition, Aprinoia, AriBio, Artery, Biogen, BioVie, Cassava, Cerecin, Diadem, EIP Pharma, Eisai, GemVax, Genentech, GAP Innovations, Janssen, Jocasta, Karuna, Lilly, Lundbeck, LSP, Merck, NervGen, Novo Nordisk, Oligomerix, Optoceutics, Ono, Otsuka, PRODEO, Prothena, reMYND, Roche, Sage Therapeutics, Signant Health, Simcere, Suven, SynapseBio, TrueBinding, Vaxxinity, and Wren Therapeutics
References to therapies are for marketing purposes only and do not guarantee results
Important: If you are currently pregnant or planning a pregnancy, always consult your doctor before starting or continuing any medication
The company explicitly makes its policy against pseudoscience known We're not about pseudoscience and half-truths is one of the first things on its homepage
